Conditions: Melanoma; Ovarian Cancer; Sarcoma; Bone; CNS-Spinal CD/MEMBR, NOS; Lymph Nodes; Soft Tissue
Interventions: Radiation: IGIMRT using a single dose of 24 Gy; Radiation: IGIMRT 27 Gy in 3 fractions
Sponsors: Memorial Sloan Kettering Cancer Center; University of Pisa; University of California, San Francisco; The Champalimaud Centre, Lisbon, Portugal
Active, not **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
